Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-cell

Explore clinical trials studying Leukemia, B-cell. Study availability and eligibility vary by location and protocol.

7 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-cell trial results

Recruiting

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

NCT05254743

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +20 more
Locations
  • Pacific Cancer Medical Center, Inc Anaheim, California, United States
  • TOI Clinical Research Cerritos, California, United States
  • Stanford School of Medicine-Cancer Clinical Trials Office Palo Alto, California, United States
  • California Cancer Associates for Research and Excellence San Marcos, California, United States
View all 143 locations
View Trial Details
Completed

Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation

NCT01087294

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +15 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • National Marrow Donor Program Minneapolis, Minnesota, United States
View Trial Details
Active, Not Recruiting

A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies

NCT05362773

Conditions
Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, Chronic Disease, +37 more
Locations
  • Colorado Blood Cancer Network Denver, Colorado, United States
  • University of Maryland, Greenbaum Comprehensive Cancer Center Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • START - Midwest Grand Rapids, Michigan, United States
View Trial Details
Active, Not Recruiting

Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.

NCT03229200

Conditions
Graft vs Host Disease, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations
  • Providence Health System - Southern California d/b/a Roy and Patricia Disney Family Cancer Center, The Roy & Patricia Disney Family Cancer Center Burbank, California, United States
  • City Of Hope National Medical Center Duarte, California, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • University of California Los Angeles (UCLA) Los Angeles, California, United States
View all 98 locations
View Trial Details

Related conditions